[1] KAHN R,HICKS J,MULLER M,et al.Consensus statement on the worldwide standardization of the hemoglobin A1C measurement:the American diabetes association,European association for the study of diabetes,international federation of clinical chemistry and laboratory medicine,and the international diabetes federation[J].Diabetes Care,2007,30(9):2399-2400.
[2] American Diabetes Association.Standards of medical care in diabetes-2012[J].Diabetes Care,2012,35(Suppl 1):S11-S39.
[3] OEI E,SAMAD N,VISSER A,et al.Use of continuous glucose monitoring in patients with diabetes on peritoneal dialysis:poor correlation with HbA1c and high incidence of hypoglycaemia[J].Diabetic Med,2016,33(9):e17-e20.
[4] NANAWARE M,MANKESHWAR R.Assessment of long term glycaemic control(HbA1c)and its correlation with biochemical and other parameters in patients with type 2 diabetes mellitus in an urban community setting[J].Int J,2017,6(2):239.
[5] D'EMDEN M C,SHAW J E,COLMAN P G,et al.The role of HbA1c in the diagnosis of diabetes mellitus in Australia[J].Med J Aust,2012,197(4):220-221.
[6] KOVATCHEV B P.Metrics for glycaemic control-from HbA1c to continuous glucose monitoring[J].Nat Rev Endocrinol,2017,13(7):425.
[7] SVENSSON E,BAGGESEN L M,JOHNSEN S P,et al.Early glycemic control and magnitude of HbA1c reduction predict cardiovascular events and mortality:population-based cohort study of 24,752 metformin initiators.[J].Diabetes Care,2017,40(6):800.
[8] JEPPSSON J O,KOBOLD U,BARR J,et al.Approved IFCC reference method for the measurement of HbA1c in human blood[J].Clin Chem Lab Med,2002,40(1):78-89.
[9] NORDIN G,DYBKAER R.Recommendation for term and measurement unit for "HbA1c"[J].Clin Chem Lab Med, 2007,45(8):1081-1082.
[10] MALCHOFF C D.Diagnosis and classification of diabetes mellitus[J].Connecticut Med,2011,1(Suppl 1):62-69.
[11] 李黎,刘铁牛.糖化血红蛋白临床检测方法进展研究[J].国际检验医学杂志,2012,33(8):954-956.
[12] 郭喜,廖远泉,沈继龙.糖化血红蛋白实验室检测技术及方法学进展[J].临床输血与检验,2017,19(6):646-650.
[13] 刘志伟,张国军,侯丽贤,等.硼酸亲和层析法检测糖化血红蛋白Alc的效果评估[J].中国热带医学,2010,10(1):110-111.
[14] 李新华,赵珂,魏芳,等.显色型亲和层析法检测糖化血红蛋白的建立及性能评估[J].中国糖尿病杂志,2016,24(10):892-896.
[15] JAISSON S,LEROY N,DESROCHES C,et al.Interference of the most frequent haemoglobin variants on quantification of HbA1c:comparison between the LC-MS(IFCC reference method)and three routinely used methods[J].Diabetes Metab,2013,39(4):363-369.
[16] REYNOLDS T M,TWOMEY P J,HARVEY T C,et al.The number of unexpected HbA variants may be a greater problem in routine practice than is generally realized[J].Diabetic Med,2004,21(9):1041-1044.
[17] 徐安平,夏勇,纪玲,等.血红蛋白变异体对糖化血红蛋白不同检测系统的影响[J].中华检验医学杂志,201538(7):470-474.
[18] LI Q,TANG J,JU Y.Effect of Hb H on HbA1c measurements as measured by IFCC reference method and affinity HPLC[J].Clin Chem Lab Med,2016,54(8):e231-e233.
[19] 李卿,刘文彬,金中淦,等.毛细管电泳法检测糖化血红蛋白的分析性能评估[J].检验医学,2015,30(2):181-184.
[20] MOIZ B,HASHMI M R,SADAF S.Performance evaluation of ion exchange and affinity chromatography for HbA1c estimation in diabetic patients with HbD:a study of 129 samples[J].Clin Biochem,2008,41(14-15):1204-1210.
[21] 梁劲松,李生.化学发光法检测糖化血红蛋白的实验评价[J].实验与检验医学,2003,21(6):503.
[22] 邹伟.免疫透射比浊法检测糖化血红蛋白的方法评价[J].临床和实验医学杂志,2010,9(7):527-528.
[23] 曹东林,雷达,张知洪,等.免疫荧光层析法测定糖化血红蛋白的效果评价[J].实用医学杂志,2015,31(11):1849-1851.
[24] 左万超,李莲,郑卫东.免疫比浊法与高效液相色谱法检测糖化血红蛋白结果的对比分析[J].山西医药杂志,2016,45(6):734-736.
[25] 田伟.糖化血红蛋白五种检测方法的评价[D].天津医科大学,2015.
[26] LIANG R L,DENG Q T,CHEN Z H,et al.Europium(Ⅲ)chelate microparticle-based lateral flow immunoassay strips for rapid and quantitative detection of antibody to hepatitis B core antigen[J].Sci Rep,2017,7(1):14093.
[27] 张丹妮.抗体选择性吸附材料的合成及性能评价[D].大连理工大学,2008.
[28] 李福刚.硝酸纤维素膜的再生处理及其吸附蛋白能力的研究[J].中国医学装备,2015,12(9):14-17.
[29] 马红艳,李强,韩雪松.胶体金诊断试剂盒中层析膜材料性能的分析[J].膜科学与技术,2002,22(6):14-19.
[30] 王华芳,李文友,何锡文,等.荧光法研究3-氨基苯硼酸与牛血清白蛋白间的相互作用[J].化学学报,2007,65(1):43-48.
[31] 李花子,王建龙,文湘华,等.聚乙烯醇-硼酸固定化方法的改进[J].环境科学研究,2002,15(5):25-27.
[32] JSR LIFE SCIENCE.IMMUTEXTM[EB/OL].https://www.jsrlifesciences.com/jp/research-reagents-ivd/immutex,2016-11-22. |